Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Precision NanoSystems, a leader in the development and application of microfluidics for the manufacture of nanomedicines; and, Arcturus Therapeutics, a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today announced a partnership for the manufacture of RNA medicines.

Under the terms of the agreement, Precision's proprietary NanoAssemblr™ platform will be used to manufacture GMP batches to support clinical studies and commercial development for RNA medicines developed using Arcturus' proprietary LUNAR™ RNA Therapeutics platform.

James Taylor, Ph.D., CEO of Precision commented, "We are delighted to partner with Arcturus to advance their pipeline of RNA medicines for the treatment of rare diseases. We have been working very closely with Arcturus during the discovery phase of the LUNAR™ products and we are excited to support ongoing development through clinical manufacture using our NanoAssemblr™ microfluidics-based platform for the manufacture of nanomedicines."

Joseph Payne, President and CEO of Arcturus added, "Arcturus is delighted to work with Precision and utilize their NanoAssemblr™ platform to advance our pipeline of RNA medicines. We believe this relationship will accelerate clinical development and enable us to effectively formulate our LUNARTM nanoparticles."

Source:

Arcturus Therapeutics, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Precision NanoSystems Inc.. (2019, June 19). Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines. News-Medical. Retrieved on December 09, 2019 from https://www.news-medical.net/news/20150111/Precision-NanoSystems-Arcturus-Therapeutics-partner-to-develop-RNA-medicines.aspx.

  • MLA

    Precision NanoSystems Inc.. "Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines". News-Medical. 09 December 2019. <https://www.news-medical.net/news/20150111/Precision-NanoSystems-Arcturus-Therapeutics-partner-to-develop-RNA-medicines.aspx>.

  • Chicago

    Precision NanoSystems Inc.. "Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines". News-Medical. https://www.news-medical.net/news/20150111/Precision-NanoSystems-Arcturus-Therapeutics-partner-to-develop-RNA-medicines.aspx. (accessed December 09, 2019).

  • Harvard

    Precision NanoSystems Inc.. 2019. Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines. News-Medical, viewed 09 December 2019, https://www.news-medical.net/news/20150111/Precision-NanoSystems-Arcturus-Therapeutics-partner-to-develop-RNA-medicines.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Alnylam second quarter revenue decreases to $20.6 million